Mireille N. Bekker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mireille N. Bekker has a total of 446 co-authors. Here are the top co-authors by number of shared publications:
- Arie Franx
Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands
18 shared publications - Lidewij Henneman
Department of Human Genetics, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands
14 shared publications - Josephus F. M. van Den Heuvel
Division of Obstetrics & Gynecology University Medical Center Utrecht Utrecht University Utrecht The Netherlands
10 shared publications - Ellis C. Becking
Department of Obstetrics Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht University Utrecht The Netherlands
9 shared publications Kim Bronsgeest
Department of Obstetrics and Gynaecology, Leiden University Medical Centre, Leiden, the Netherlands
9 shared publications- Neeltje Crombag
Department of Obstetrics and Gynecology University Medical Center Utrecht Utrecht The Netherlands
9 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Low‐Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial
Objective: To evaluate the effectiveness of low‐dose aspirin in the prevention of recurrent preterm birth (PTB) in women with signs of maternal vascular malperfusion (MVM) in the placenta of the previous spontaneous PTB. Design: Secondary analysis of the APRIL study. Setting: The APRIL study, conducted in 34 centres in the Netherlands, evaluated low‐dose aspirin versus placebo in the prevention of recurrent PTB after spontaneous PTB. Population: Women with a history of spontaneous PTB participating in the APRIL study, with available placenta histology reports from the previous spontaneous PTB. Methods: Placental histology reports were retrieved from participating centres and categorized for presence of MVM as defined by the Amsterdam criteria. Main Outcome Measures: Recurrent PTB. Results: Placental histology reports of the previous spontaneous PTB were available for 41.3% (160/387) of participants, and MVM was present in 27.5% (44/160). In participants with MVM, recurrent PTB occurred in 4.2% (1/24) of the aspirin group, versus in 45.0% (9/20) in the placebo group (Relative Risk (RR) 0.09; 95% Confidence Interval (CI) 0.01–0.43; p = 0.02). In participants without MVM, PTB occurred in 29.3% (17/58) in the aspirin group compared to 17.2% (10/58) in the placebo group (RR 1.70; 95% CI 0.87–3.56; p = 0.13). Conclusion: In women with a history of spontaneous PTB and signs of MVM in the placenta, a vascular‐mediated subgroup, the use of low‐dose aspirin in a subsequent pregnancy was associated with a lower rate of recurrent PTB.
- 23 October 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Open AccessLow‐Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial
Objective: To evaluate the effectiveness of low‐dose aspirin in the prevention of recurrent preterm birth (PTB) in women with signs of maternal vascular malperfusion (MVM) in the placenta of the previous spontaneous PTB. Design: Secondary analysis of the APRIL study. Setting: The APRIL study, conducted in 34 centres in the Netherlands, evaluated low‐dose aspirin versus placebo in the prevention of recurrent PTB after spontaneous PTB. Population: Women with a history of spontaneous PTB participating in the APRIL study, with available placenta histology reports from the previous spontaneous PTB. Methods: Placental histology reports were retrieved from participating centres and categorized for presence of MVM as defined by the Amsterdam criteria. Main Outcome Measures: Recurrent PTB. Results: Placental histology reports of the previous spontaneous PTB were available for 41.3% (160/387) of participants, and MVM was present in 27.5% (44/160). In participants with MVM, recurrent PTB occurred in 4.2% (1/24) of the aspirin group, versus in 45.0% (9/20) in the placebo group (Relative Risk (RR) 0.09; 95% Confidence Interval (CI) 0.01–0.43; p = 0.02). In participants without MVM, PTB occurred in 29.3% (17/58) in the aspirin group compared to 17.2% (10/58) in the placebo group (RR 1.70; 95% CI 0.87–3.56; p = 0.13). Conclusion: In women with a history of spontaneous PTB and signs of MVM in the placenta, a vascular‐mediated subgroup, the use of low‐dose aspirin in a subsequent pregnancy was associated with a lower rate of recurrent PTB.
- Open Access
Telemonitoring for high-risk pregnancies (PregnaDigit EU): an international hybrid type 2 study protocol
- Open Access
- 12 August 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (3)
MRI-based assessment of fetal brain gyrification: Reliability across two methods
- 12 August 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (3)
Open AccessMRI-based assessment of fetal brain gyrification: Reliability across two methods
- Open Access
- 6 August 2026
- Published by Springer Nature in Research Square
Shared Decision-Making, Decisional Conflict and Regret in Periviable Birth Counseling: A Multicenter Cohort Study in the Context of a Decision Aid
Objective To describe perceived shared decision-making (SDM), decisional conflict (DC) and decision regret (DR) in prenatal counseling for imminent extreme premature birth, using a decision aid (DA). Study design Multicenter, cohort study measuring perceived SDM in parents and physicians, and DC and DR in parents at counseling, 1-, and 3-months post decision-making on palliative comfort care versus early intensive care (scales 0-100). A digital DA was offered before prenatal counseling for birth between 24 and 26 weeks of gestation. Results 124 participants from 47 prenatal counseling sessions were included (36 pregnant persons, 25 partners, 31 obstetricians, 32 neonatologists). Perceived SDM was high in parents and physicians (SDM-Q-9 and SDM-Q-doc; median 86.7 and 77.8). DC was low (median 20.3), as was DR at 1 and 3 months (median 5 and 10). Conclusion Perceived SDM was high, and DC and DR were generally low in periviability counseling using a DA.
- 6 August 2026
- Published by Springer Nature in Research Square
Open AccessShared Decision-Making, Decisional Conflict and Regret in Periviable Birth Counseling: A Multicenter Cohort Study in the Context of a Decision Aid
Objective To describe perceived shared decision-making (SDM), decisional conflict (DC) and decision regret (DR) in prenatal counseling for imminent extreme premature birth, using a decision aid (DA). Study design Multicenter, cohort study measuring perceived SDM in parents and physicians, and DC and DR in parents at counseling, 1-, and 3-months post decision-making on palliative comfort care versus early intensive care (scales 0-100). A digital DA was offered before prenatal counseling for birth between 24 and 26 weeks of gestation. Results 124 participants from 47 prenatal counseling sessions were included (36 pregnant persons, 25 partners, 31 obstetricians, 32 neonatologists). Perceived SDM was high in parents and physicians (SDM-Q-9 and SDM-Q-doc; median 86.7 and 77.8). DC was low (median 20.3), as was DR at 1 and 3 months (median 5 and 10). Conclusion Perceived SDM was high, and DC and DR were generally low in periviability counseling using a DA.
- Open Access
- 29 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Facilitators and Barriers to Cross-border Implementation of Cardiotocography Telemonitoring in High-Risk Pregnancies (PregnaDigit EU): a Qualitative Pre-Implementation Study (Preprint)
BACKGROUND Telemonitoring is a promising response to global healthcare challenges, including workforce shortages and rising costs. In high-risk pregnancy care, remote cardiotocography (CTG) monitoring has been shown to reduce hospital-based care while maintaining safety, improving patient experience, and reducing costs; however, implementation remains scarce. Insights into implementation challenges, particularly across international settings, remain limited. OBJECTIVE The present study, conducted by the PregnaDigit EU consortium, aimed to identify shared and setting-specific pre-implementation facilitators and barriers to telemonitoring in order to inform scalable strategies across international healthcare settings. METHODS This qualitative pre-implementation study employed semi-structured interviews with obstetric healthcare providers at Karolinska University Hospital (Stockholm, Sweden) and Vall d’Hebron University Hospital (Barcelona, Spain). Interview guide development was based on the Consolidated Framework for Implementation Research (CFIR), and data were analysed using the Qualitative Analysis Guide of Leuven (QUAGOL). RESULTS Data saturation was reached after 15 interviews. Facilitators and barriers clustered across four themes: target population, implementation readiness, safety, and patient impact. Patient eligibility for telemonitoring was shaped by medical, personal, and socioeconomic factors. While telemonitoring was considered feasible and promising, readiness was constrained by workload concerns and limited staff involvement and knowledge. Clear protocols and trained staff acted as facilitators when available and barriers when absent. Safety concerns focused on home emergencies and reduced personal connection, with setting-specific differences in safety risk mechanisms and technical reliability. CONCLUSIONS Implementation of CTG telemonitoring for high-risk pregnancies is facilitated by careful patient selection, implementation readiness, safety mechanisms, and patient impact. This cross-border pre-implementation study highlights the need for local due diligence and targeted training early in implementation, as setting-specific factors require tailored strategies to support scalable and sustainable implementation across healthcare settings.
- 29 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFacilitators and Barriers to Cross-border Implementation of Cardiotocography Telemonitoring in High-Risk Pregnancies (PregnaDigit EU): a Qualitative Pre-Implementation Study (Preprint)
BACKGROUND Telemonitoring is a promising response to global healthcare challenges, including workforce shortages and rising costs. In high-risk pregnancy care, remote cardiotocography (CTG) monitoring has been shown to reduce hospital-based care while maintaining safety, improving patient experience, and reducing costs; however, implementation remains scarce. Insights into implementation challenges, particularly across international settings, remain limited. OBJECTIVE The present study, conducted by the PregnaDigit EU consortium, aimed to identify shared and setting-specific pre-implementation facilitators and barriers to telemonitoring in order to inform scalable strategies across international healthcare settings. METHODS This qualitative pre-implementation study employed semi-structured interviews with obstetric healthcare providers at Karolinska University Hospital (Stockholm, Sweden) and Vall d’Hebron University Hospital (Barcelona, Spain). Interview guide development was based on the Consolidated Framework for Implementation Research (CFIR), and data were analysed using the Qualitative Analysis Guide of Leuven (QUAGOL). RESULTS Data saturation was reached after 15 interviews. Facilitators and barriers clustered across four themes: target population, implementation readiness, safety, and patient impact. Patient eligibility for telemonitoring was shaped by medical, personal, and socioeconomic factors. While telemonitoring was considered feasible and promising, readiness was constrained by workload concerns and limited staff involvement and knowledge. Clear protocols and trained staff acted as facilitators when available and barriers when absent. Safety concerns focused on home emergencies and reduced personal connection, with setting-specific differences in safety risk mechanisms and technical reliability. CONCLUSIONS Implementation of CTG telemonitoring for high-risk pregnancies is facilitated by careful patient selection, implementation readiness, safety mechanisms, and patient impact. This cross-border pre-implementation study highlights the need for local due diligence and targeted training early in implementation, as setting-specific factors require tailored strategies to support scalable and sustainable implementation across healthcare settings.
- Open Access
- 2 June 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (9) , 1698-1706
Self‐administered tele‐ultrasound in fetal telemonitoring: Prospective study
Introduction: Digital innovations in ultrasound are enabling tele‐ultrasound and remote guidance, offering new opportunities to strengthen hospital‐at‐home care. This study evaluated the feasibility and user experience of self‐administered ultrasound by pregnant women with real‐time guidance. Material and Methods: This prospective observational cohort study included pregnant women with uncomplicated singleton pregnancies between 24 and 37 weeks of gestation. Participants used the portable tele‐ultrasound device Pulsenmore ES (Pulsenmore Ltd., Omer) at home to perform clinician‐guided, real‐time transabdominal 2D scans twice weekly, completing eight scans over a 28‐day period. Real‐time guidance was provided by experienced obstetric healthcare professionals. Primary outcome was feasibility, including image acquisition, interpretability, interobserver agreement for saved images, and technical aspects. Secondary outcomes included the System Usability Scale and the self‐developed Telemonitoring Survey for user experience. Additionally, a focus group meeting assessed obstetric healthcare professionals' perspectives on the system. Results: Thirty pregnant women participated, with a mean age of 32.6 years, median body mass index of 23.3 kg/m 2 , and a mean gestational age of 29 weeks (range 24.3–34.5). All participants completed eight ultrasound scans, resulting in 240 tele‐ultrasound examinations with a 100% success rate for predefined parameters, including fetal position, fetal heart activity, deepest pocket of amniotic fluid, and placental location. Across the study, remote connection and image acquisition times shortened to a median of 5 and 4 min, respectively. Retrospective analysis was possible for 226 scans, yielding a 99.9% parameter identification rate and perfect interobserver agreement (100%). Technical errors occurred in 16.3% of examinations, mainly due to connection issues. No association was found between scan duration and maternal or pregnancy characteristics such as gestational age, body mass index, and placental location. Participant experience was highly positive, with a mean System Usability Scale score of 80.7 and a satisfaction score of 4.4/5 on the Telemonitoring Survey, reflecting excellent usability. Ultrasound experts found the system user‐friendly, with sufficient image quality and functionality. Conclusions: Self‐administered fetal tele‐ultrasound is feasible and associated with high user satisfaction and usability. This study supported its potential as a complementary tool in obstetric care, highlighting tele‐ultrasound's promise to enhance accessibility, patient engagement, and strengthen hospital‐at‐home strategies.
- 2 June 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (9) , 1698-1706
Open AccessSelf‐administered tele‐ultrasound in fetal telemonitoring: Prospective study
Introduction: Digital innovations in ultrasound are enabling tele‐ultrasound and remote guidance, offering new opportunities to strengthen hospital‐at‐home care. This study evaluated the feasibility and user experience of self‐administered ultrasound by pregnant women with real‐time guidance. Material and Methods: This prospective observational cohort study included pregnant women with uncomplicated singleton pregnancies between 24 and 37 weeks of gestation. Participants used the portable tele‐ultrasound device Pulsenmore ES (Pulsenmore Ltd., Omer) at home to perform clinician‐guided, real‐time transabdominal 2D scans twice weekly, completing eight scans over a 28‐day period. Real‐time guidance was provided by experienced obstetric healthcare professionals. Primary outcome was feasibility, including image acquisition, interpretability, interobserver agreement for saved images, and technical aspects. Secondary outcomes included the System Usability Scale and the self‐developed Telemonitoring Survey for user experience. Additionally, a focus group meeting assessed obstetric healthcare professionals' perspectives on the system. Results: Thirty pregnant women participated, with a mean age of 32.6 years, median body mass index of 23.3 kg/m 2 , and a mean gestational age of 29 weeks (range 24.3–34.5). All participants completed eight ultrasound scans, resulting in 240 tele‐ultrasound examinations with a 100% success rate for predefined parameters, including fetal position, fetal heart activity, deepest pocket of amniotic fluid, and placental location. Across the study, remote connection and image acquisition times shortened to a median of 5 and 4 min, respectively. Retrospective analysis was possible for 226 scans, yielding a 99.9% parameter identification rate and perfect interobserver agreement (100%). Technical errors occurred in 16.3% of examinations, mainly due to connection issues. No association was found between scan duration and maternal or pregnancy characteristics such as gestational age, body mass index, and placental location. Participant experience was highly positive, with a mean System Usability Scale score of 80.7 and a satisfaction score of 4.4/5 on the Telemonitoring Survey, reflecting excellent usability. Ultrasound experts found the system user‐friendly, with sufficient image quality and functionality. Conclusions: Self‐administered fetal tele‐ultrasound is feasible and associated with high user satisfaction and usability. This study supported its potential as a complementary tool in obstetric care, highlighting tele‐ultrasound's promise to enhance accessibility, patient engagement, and strengthen hospital‐at‐home strategies.
- Open Access
- 10 March 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (7) , 1373-1380
Dedicated First‐Trimester Anomaly Scan in a National Prenatal Screening Program and Timing of Diagnosis: The Prospective IMITAS Cohort Study
Objective: To determine the diagnostic yield of a nationally implemented first‐trimester anomaly scan (FTAS), compared to standard obstetric care with a second‐trimester anomaly scan. Design: Prospective observational cohort study. Setting: Nationwide prenatal screening program in the Netherlands. Population: Pregnant women referred for suspected fetal anomalies with subsequent abnormal diagnostic scans in 2021–2022. Methods: All fetal diagnoses < 18 weeks' gestational age (GA) were registered: 8 months before (BEFORE) and 1 year after (AFTER) FTAS implementation. BEFORE‐cohort: referrals after routine scans (e.g., dating scans). AFTER‐cohort: all referrals, including FTAS. Corrections were made for missing referrals < 12 + 3 weeks in the AFTER‐cohort. Time adjustment was made in the BEFORE‐cohort. Anomalies were categorised as: First‐Trimester Major Anomalies (FTMA), often detectable anomalies and other anomalies. Main Outcome Measures: Number of fetal anomalies, time to final diagnosis, GA at termination of pregnancy (TOP). Results: Abnormal diagnostic scans increased from 750 to 1261 (BEFORE vs. AFTER) with definitive diagnoses in 609 vs. 940. Time to diagnosis and GA at TOP in c‐BEFORE were comparable to c‐AFTER (11 vs. 13 days and GA 14 + 6 vs. 15 + 1, respectively). FTAS increased the detection of often detectable and other anomalies (53 vs. 124 and 248 vs. 474, respectively). FTMA slightly increased (308 vs. 342). Conclusions: FTAS substantially increases detection of fetal anomalies, primarily often detectable and other anomalies. Overall GA at diagnosis or TOP increased marginally, but some cases required an extended period of diagnostic evaluation.
- 10 March 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (7) , 1373-1380
Open AccessDedicated First‐Trimester Anomaly Scan in a National Prenatal Screening Program and Timing of Diagnosis: The Prospective IMITAS Cohort Study
Objective: To determine the diagnostic yield of a nationally implemented first‐trimester anomaly scan (FTAS), compared to standard obstetric care with a second‐trimester anomaly scan. Design: Prospective observational cohort study. Setting: Nationwide prenatal screening program in the Netherlands. Population: Pregnant women referred for suspected fetal anomalies with subsequent abnormal diagnostic scans in 2021–2022. Methods: All fetal diagnoses < 18 weeks' gestational age (GA) were registered: 8 months before (BEFORE) and 1 year after (AFTER) FTAS implementation. BEFORE‐cohort: referrals after routine scans (e.g., dating scans). AFTER‐cohort: all referrals, including FTAS. Corrections were made for missing referrals < 12 + 3 weeks in the AFTER‐cohort. Time adjustment was made in the BEFORE‐cohort. Anomalies were categorised as: First‐Trimester Major Anomalies (FTMA), often detectable anomalies and other anomalies. Main Outcome Measures: Number of fetal anomalies, time to final diagnosis, GA at termination of pregnancy (TOP). Results: Abnormal diagnostic scans increased from 750 to 1261 (BEFORE vs. AFTER) with definitive diagnoses in 609 vs. 940. Time to diagnosis and GA at TOP in c‐BEFORE were comparable to c‐AFTER (11 vs. 13 days and GA 14 + 6 vs. 15 + 1, respectively). FTAS increased the detection of often detectable and other anomalies (53 vs. 124 and 248 vs. 474, respectively). FTMA slightly increased (308 vs. 342). Conclusions: FTAS substantially increases detection of fetal anomalies, primarily often detectable and other anomalies. Overall GA at diagnosis or TOP increased marginally, but some cases required an extended period of diagnostic evaluation.
- Open Access
- 3 March 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (4) , 523-532
Preferences of Pregnant Women and Healthcare Professionals on First‐Trimester Ultrasound Screening for Fetal Anomalies: A Discrete Choice Experiment
Objective: The first‐trimester anomaly scan (FTAS) allows early detection of fetal structural anomalies. Decisions on timing and scan protocol influence its performance. Understanding how pregnant women and healthcare professionals value these aspects is essential for shaping screening programs. This study aims to identify which aspects of first‐trimester ultrasound screening are considered most important. Method: A discrete choice experiment was conducted between July and August 2025. It included five attributes: sensitivity (30%, 50%, 90%), gestational age at diagnosis (12, 16, 22 weeks), false positive rate (20%, 40%, 60%), false negative rate (0.1%, 1%, 5%) and types of anomalies detected (most severe only vs. most severe and other). Additionally, general attitudes toward the FTAS were assessed. Results: Questionnaires were completed by 1963 pregnant women who opted for FTAS and 1068 healthcare professionals (203 medical doctors, 865 primary care professionals). Most important attributes for pregnant women and healthcare professionals were sensitivity and false positive rate. 85.1% of pregnant women and 58.1% of healthcare professionals (strongly) agreed that the FTAS should be available to pregnant women. Conclusion: Pregnant women and healthcare professionals support FTAS availability. Optimization should focus on maximizing sensitivity and minimizing false positive rates, whereas gestational age at diagnosis and the range of anomalies detected are considered less important in influencing preferences.
- 3 March 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (4) , 523-532
Open AccessPreferences of Pregnant Women and Healthcare Professionals on First‐Trimester Ultrasound Screening for Fetal Anomalies: A Discrete Choice Experiment
Objective: The first‐trimester anomaly scan (FTAS) allows early detection of fetal structural anomalies. Decisions on timing and scan protocol influence its performance. Understanding how pregnant women and healthcare professionals value these aspects is essential for shaping screening programs. This study aims to identify which aspects of first‐trimester ultrasound screening are considered most important. Method: A discrete choice experiment was conducted between July and August 2025. It included five attributes: sensitivity (30%, 50%, 90%), gestational age at diagnosis (12, 16, 22 weeks), false positive rate (20%, 40%, 60%), false negative rate (0.1%, 1%, 5%) and types of anomalies detected (most severe only vs. most severe and other). Additionally, general attitudes toward the FTAS were assessed. Results: Questionnaires were completed by 1963 pregnant women who opted for FTAS and 1068 healthcare professionals (203 medical doctors, 865 primary care professionals). Most important attributes for pregnant women and healthcare professionals were sensitivity and false positive rate. 85.1% of pregnant women and 58.1% of healthcare professionals (strongly) agreed that the FTAS should be available to pregnant women. Conclusion: Pregnant women and healthcare professionals support FTAS availability. Optimization should focus on maximizing sensitivity and minimizing false positive rates, whereas gestational age at diagnosis and the range of anomalies detected are considered less important in influencing preferences.
- Open Access
- 26 January 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (3) , 368-381
The Sooner, the Better: Neuroprotective Strategies in Fetuses With Congenital Heart Disease
Congenital heart disease (CHD) is the most frequent congenital malformation at birth and is associated with neurodevelopmental impairments. Alterations in cardiovascular physiology can lead to reduced cerebral blood perfusion and oxygenation, which negatively affects brain growth and maturation. Advanced imaging studies indicate that these aberrations in brain development can manifest as early as in utero, resulting from the inability of the fetal circulatory system to meet the increased metabolic demands of the brain. Fetal brain dysmaturation increases the susceptibility to postnatal brain injury and is related to adverse long‐term neurodevelopmental outcomes throughout childhood. This emphasizes the potential for effective prenatal neuroprotective strategies in fetuses with CHD, as optimization of their intrauterine environment may prevent irreversible neurological damage and minimize long‐term neurodevelopmental comorbidities. This review provides a comprehensive overview of prenatal neuroprotective strategies in fetuses with critical CHD, including in utero therapeutic interventions, prenatal surgical cardiac interventions, and modifiable prenatal and perinatal risk factors.
- 26 January 2026
- Published by Wiley in Prenatal Diagnosis
- Vol. 46 (3) , 368-381
Open AccessThe Sooner, the Better: Neuroprotective Strategies in Fetuses With Congenital Heart Disease
Congenital heart disease (CHD) is the most frequent congenital malformation at birth and is associated with neurodevelopmental impairments. Alterations in cardiovascular physiology can lead to reduced cerebral blood perfusion and oxygenation, which negatively affects brain growth and maturation. Advanced imaging studies indicate that these aberrations in brain development can manifest as early as in utero, resulting from the inability of the fetal circulatory system to meet the increased metabolic demands of the brain. Fetal brain dysmaturation increases the susceptibility to postnatal brain injury and is related to adverse long‐term neurodevelopmental outcomes throughout childhood. This emphasizes the potential for effective prenatal neuroprotective strategies in fetuses with CHD, as optimization of their intrauterine environment may prevent irreversible neurological damage and minimize long‐term neurodevelopmental comorbidities. This review provides a comprehensive overview of prenatal neuroprotective strategies in fetuses with critical CHD, including in utero therapeutic interventions, prenatal surgical cardiac interventions, and modifiable prenatal and perinatal risk factors.